These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 9750467

  • 1. [Pulsed doses of calcitriol in the treatment of secondary hyperparathyroidism in patients on hemodialysis].
    Sotorník I, Petrásek R, Schück O, Adamec M, Smrcková I, Tocík J.
    Vnitr Lek; 1997 Sep; 43(9):584-91. PubMed ID: 9750467
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism.
    Malberti F, Corradi B, Cosci P, Colecchia M, Leopardi O, Grossi L, Oldini C, Imbasciati E.
    Nephrol Dial Transplant; 1996 Jan; 11(1):81-7. PubMed ID: 8649657
    [Abstract] [Full Text] [Related]

  • 4. Effect of the mode of calcitriol administration on PTH-ionized calcium relationship in uraemic patients with secondary hyperparathyroidism.
    Caravaca F, Cubero JJ, Jimenez F, López JM, Aparicio A, Cid MC, Pizarro JL, Liso J, Santos I.
    Nephrol Dial Transplant; 1995 Jan; 10(5):665-70. PubMed ID: 7566580
    [Abstract] [Full Text] [Related]

  • 5. A controlled trial of the early treatment of secondary hyperparathyroidism with calcitriol in hemodialysis patients.
    Delmez JA, Kelber J, Norwood KY, Giles KS, Slatopolsky E.
    Clin Nephrol; 2000 Oct; 54(4):301-8. PubMed ID: 11076106
    [Abstract] [Full Text] [Related]

  • 6. Calcitriol pulse therapy and histology of parathyroid glands in hemodialysis patients.
    Lomonte C, Martino R, Selvaggiolo M, Bona RM, Cazzato F, Milano R, Chiarulli G, Basile C.
    J Nephrol; 2003 Oct; 16(5):716-20. PubMed ID: 14733419
    [Abstract] [Full Text] [Related]

  • 7. [Research on the treatment of secondary hyperparathyroidism as a complication of chronic renal failure].
    Sugimura T.
    Nihon Jinzo Gakkai Shi; 1991 Nov; 33(11):1119-34. PubMed ID: 1808363
    [Abstract] [Full Text] [Related]

  • 8. Comparative effect of oral or intravenous calcitriol on secondary hyperparathyroidism in chronic hemodialysis patients.
    Liou HH, Chiang SS, Huang TP, Shieh SD, Akmal M.
    Miner Electrolyte Metab; 1994 Nov; 20(3):97-102. PubMed ID: 7816008
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
    Ogata H, Koiwa F, Shishido K, Takahashi K, Ito H, Kinugasa E, Taguchi S.
    Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
    [Abstract] [Full Text] [Related]

  • 11. Effect of vitamin C on parathyroid hormone in hemodialysis patients with mild to moderate secondary hyperparathyroidism.
    Sanadgol H, Bayani M, Mohammadi M, Bayani B, Mashhadi MA.
    Iran J Kidney Dis; 2011 Nov; 5(6):410-5. PubMed ID: 22057074
    [Abstract] [Full Text] [Related]

  • 12. Frequent recurrence of secondary hyperparathyroidism after pulse oral calcitriol withdrawal in PD patients.
    Bajo MA, Selgas R, Possante C, Aguilera A, Sánchez C, Diaz C, de Alvaro F, Martinez ME.
    Adv Perit Dial; 1997 Nov; 13():239-43. PubMed ID: 9360690
    [Abstract] [Full Text] [Related]

  • 13. A crossover comparison of intermittent oral and intravenous administration of calcitriol on the parathyroid hormone concentration in hemodialysis patients.
    Peng SJ, Yang CS, Ferng SH, Chen LY.
    Miner Electrolyte Metab; 1997 Nov; 23(1):13-8. PubMed ID: 9058364
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effective treatment of secondary hyperparathyroidism in hemodialysis patients by titration of intravenous calcitriol dosage.
    Grekas D, Balaskas E, Kampouris H, Benos A, Konstantinou A, Sioullis A, Tourkantonis A.
    Clin Nephrol; 1999 Sep; 52(3):167-71. PubMed ID: 10499312
    [Abstract] [Full Text] [Related]

  • 16. Evidence for both abnormal set point of PTH stimulation by calcium and adaptation to serum calcium in hemodialysis patients with hyperparathyroidism.
    Rodriguez M, Caravaca F, Fernandez E, Borrego MJ, Lorenzo V, Cubero J, Martin-Malo A, Betriu A, Rodriguez AP, Felsenfeld AJ.
    J Bone Miner Res; 1997 Mar; 12(3):347-55. PubMed ID: 9076577
    [Abstract] [Full Text] [Related]

  • 17. [The oral 1-25 dihydroxyvitamin D3 pulse therapy in hemodialysis patients for the early treatment of secondary hyperparathyroidism].
    Kawabe M, Shimizu M, Takeuchi M, Matsunobu S, Hayama N, Iino Y, Hara K, Terashi A.
    Nihon Jinzo Gakkai Shi; 1992 Jul; 34(7):807-11. PubMed ID: 1479720
    [Abstract] [Full Text] [Related]

  • 18. Comparison of intermittent oral and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism.
    Fischer ER, Harris DC.
    Clin Nephrol; 1993 Oct; 40(4):216-20. PubMed ID: 8261678
    [Abstract] [Full Text] [Related]

  • 19. Secondary hyperparathyroidism in CAPD patients: its suppressibility with high doses of calcitriol.
    Felipe C, Miranda B, Selgas R, Martinez ME, Miguel JL, Moreno F, Caparros G, Torre A, Sicilia LS.
    Adv Perit Dial; 1990 Oct; 6():238-41. PubMed ID: 1982816
    [Abstract] [Full Text] [Related]

  • 20. [A trial of suppressing secondary hyperparathyroidism by oral high dose therapy of 1, 25-dihydroxyvitamin D3].
    Shigematsu T, Kawaguchi Y, Unemura S, Suzuki M, Yamamoto H, Morita T, Momose M, Ogawa A, Nakayama M, Miyahara T.
    Nihon Jinzo Gakkai Shi; 1989 Apr; 31(4):393-401. PubMed ID: 2787433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.